Search

Your search keyword '"Lewis, Basil S."' showing total 24 results
Start Over Author "Lewis, Basil S." Journal european heart journal
24 results on '"Lewis, Basil S."'

2. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Author

Roffi, Marco, Patrono, Carlo, Collet, Jean-Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J., Borger, Michael A., Brotons, Carlos, Chew, Derek P., Gencer, Baris, Hasenfuss, Gerd, Kjeldsen, Keld, Lancellotti, Patrizio, Landmesser, Ulf, Mehilli, Julinda, Mukherjee, Debabrata, Storey, Robert F., Windecker, Stephan, Baumgartner, Helmut, Gaemperli, Oliver, Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Baigent, Colin, Bueno, Héctor, Bugiardini, Raffaele, Carerj, Scipione, Casselman, Filip, Cuisset, Thomas, Erol, Çetin, Fitzsimons, Donna, Halle, Martin, Hamm, Christian, Hildick-Smith, David, Huber, Kurt, Iliodromitis, Efstathios, James, Stefan, Lewis, Basil S., Lip, Gregory Y. H., Piepoli, Massimo F., Richter, Dimitrios, Rosemann, Thomas, Sechtem, Udo, Steg, Ph. Gabriel, Vrints, Christian, and Luis Zamorano, Jose

Published
2016
Full Text
View/download PDF

3. Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy

Author

Aboyans, Victor, primary, Bauersachs, Rupert, additional, Mazzolai, Lucia, additional, Brodmann, Marianne, additional, Palomares, José F Rodriguez, additional, Debus, Sebastian, additional, Collet, Jean-Philippe, additional, Drexel, Heinz, additional, Espinola-Klein, Christine, additional, Lewis, Basil S, additional, Roffi, Marco, additional, Sibbing, Dirk, additional, Sillesen, Henrik, additional, Stabile, Eugenio, additional, Schlager, Oliver, additional, and De Carlo, Marco, additional

Published
2021
Full Text
View/download PDF

5. 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease : The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC)

Author

Pelliccia, Antonio, Sharma, Sanjay, Gati, Sabiha, Bäck, Maria, Börjesson, Mats, Caselli, Stefano, Collet, Jean-Philippe, Corrado, Domenico, Drezner, Jonathan A., Halle, Martin, Hansen, Dominique, Heidbüchel, Hein, Myers, Jonathan, Niebauer, Josef, Papadakis, Michael, Piepoli, Massimo Francesco, Prescott, Eva, Roos-Hesselink, Jolien W., Graham Stuart, A., Taylor, Rod S., Thompson, Paul D., Tiberi, Monica, Vanhees, Luc, Wilhelm, Matthias, Guazzi, Marco, La Gerche, André, Aboyans, Victor, Adami, Paolo Emilio, Backs, Johannes, Baggish, Aaron, Basso, Cristina, Biffi, Alessandro, Bucciarelli-Ducci, Chiara, Camm, A. John, Claessen, Guido, Delgado, Victoria, Elliott, Perry M., Galderisi, Maurizio, Gale, Chris P., Gray, Belinda, Haugaa, Kristina Hermann, Iung, Bernard, Katus, Hugo A., Keren, Andre, Leclercq, Christophe, Lewis, Basil S., Mont, Lluis, Mueller, Christian, Petersen, Steffen E., Petronio, Anna Sonia, Roffi, Marco, Savonen, Kai, Serratosa, Luis, Shlyakhto, Evgeny, Simpson, Iain A., Sitges, Marta, Solberg, Erik Ekker, Sousa-Uva, Miguel, van Craenenbroeck, Emeline, Van De Heyning, Caroline, Wijns, William, and ESC Scientific Document Group

Subjects
Human medicine
Published
2021

6. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study

Author

Jankowska, Ewa A, primary, Kirwan, Bridget-Anne, additional, Kosiborod, Mikhail, additional, Butler, Javed, additional, Anker, Stefan D, additional, McDonagh, Theresa, additional, Dorobantu, Maria, additional, Drozdz, Jarosław, additional, Filippatos, Gerasimos, additional, Keren, Andre, additional, Khintibidze, Irakli, additional, Kragten, Hans, additional, Martinez, Felipe A, additional, Metra, Marco, additional, Milicic, Davor, additional, Nicolau, José C, additional, Ohlsson, Marcus, additional, Parkhomenko, Alexander, additional, Pascual-Figal, Domingo A, additional, Ruschitzka, Frank, additional, Sim, David, additional, Skouri, Hadi, additional, van der Meer, Peter, additional, Lewis, Basil S, additional, Comin-Colet, Josep, additional, von Haehling, Stephan, additional, Cohen-Solal, Alain, additional, Danchin, Nicolas, additional, Doehner, Wolfram, additional, Dargie, Henry J, additional, Motro, Michael, additional, Friede, Tim, additional, Fabien, Vincent, additional, Dorigotti, Fabio, additional, Pocock, Stuart, additional, and Ponikowski, Piotr, additional

Published
2021
Full Text
View/download PDF

7. Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants

Author

Bosch, Jackie, primary, Lonn, Eva M, additional, Jung, Hyejung, additional, Zhu, Jun, additional, Liu, Lisheng, additional, Lopez-Jaramillo, Patricio, additional, Pais, Prem, additional, Xavier, Denis, additional, Diaz, Rafael, additional, Dagenais, Gilles, additional, Dans, Antonio, additional, Avezum, Alvaro, additional, Piegas, Leopoldo S, additional, Parkhomenko, Alexander, additional, Keltai, Kati, additional, Keltai, Matyas, additional, Sliwa, Karen, additional, Held, Claus, additional, Peters, Ronald J G, additional, Lewis, Basil S, additional, Jansky, Petr, additional, Yusoff, Khalid, additional, Khunti, Kamlesh, additional, Toff, William D, additional, Reid, Christopher M, additional, Varigos, John, additional, Joseph, Philip, additional, Leiter, Lawrence A, additional, and Yusuf, Salim, additional

Published
2021
Full Text
View/download PDF

8. Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

Author

Alexander, John H., Lopes, Renato D., Thomas, Laine, Alings, Marco, Atar, Dan, Aylward, Philip, Goto, Shinya, Hanna, Michael, Huber, Kurt, Husted, Steen, Lewis, Basil S., McMurray, John J.V., Pais, Prem, Pouleur, Hubert, Steg, Philippe Gabriel, Verheugt, Freek W.A., Wojdyla, Daniel M., Granger, Christopher B., and Wallentin, Lars

Published
2014
Full Text
View/download PDF

12. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Author

Collet, Jean-Philippe, Thiele, Holger, Barbato, Emanuele, Barthélémy, Olivier, Bauersachs, Johann, Bhatt, Deepak L, Dendale, Paul, Dorobantu, Maria, Edvardsen, Thor, Folliguet, Thierry, Gale, Chris P, Gilard, Martine, Jobs, Alexander, Jüni, Peter, Lambrinou, Ekaterini, Lewis, Basil S, Mehilli, Julinda, Meliga, Emanuele, Merkely, Béla, and Mueller, Christian

Subjects
ACUTE coronary syndrome, CARDIAC patients, MYOCARDIAL infarction diagnosis, HEART disease diagnosis, ELECTROCARDIOGRAPHY, CORONARY angiography
Abstract

The article discusses the 2020 guidelines presented by the European Society of Cardiology (ESC) for acute coronary syndrome (ACS) management in patients without persistent ST-segment elevation. Topics explored include the clinical characteristics and diagnosis of myocardial infarction, the administration of electrocardiogram to assess patients with suspected ACS, and the patients which may not be considered for invasive coronary angiography.

Published
2021
Full Text
View/download PDF

13. Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1

Author

Sulzgruber, Patrick, primary, Wassmann, Sven, additional, Semb, Anne Grete, additional, Doehner, Wolfram, additional, Widimsky, Petr, additional, Gremmel, Thomas, additional, Kaski, Juan Carlos, additional, Savarese, Gianluigi, additional, Rosano, Giuseppe M C, additional, Borghi, Claudio, additional, Kjeldsen, Keld, additional, Torp-Pedersen, Christian, additional, Schmidt, Thomas Andersen, additional, Lewis, Basil S, additional, Drexel, Heinz, additional, Tamargo, Juan, additional, Atar, Dan, additional, Agewall, Stefan, additional, and Niessner, Alexander, additional

Published
2019
Full Text
View/download PDF

14. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Author

Roffi, Marco, Patrono, Carlo, Collet, Jean-Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J, Borger, Michael A, Brotons, Carlos, Chew, Derek P, Gencer, Baris, Hasenfuss, Gerd, Kjeldsen, Keld, Lancellotti, Patrizio, Landmesser, Ulf, Mehilli, Julinda, Mukherjee, Debabrata, Storey, Robert F, Windecker, Stephan, Patrono, Marco, Baumgartner, Helmut, Gaemperli, Oliver, Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Baigent, Colin, Bueno, Héctor, Bugiardini, Raffaele, Carerj, Scipione, Casselman, Filip, Cuisset, Thomas, Erol, Çetin, Fitzsimons, Donna, Halle, Martin, Hamm, Christian, Hildick-Smith, David, Huber, Kurt, Iliodromitis, Efstathios, James, Stefan, Lewis, Basil S, Lip, Gregory y H, Piepoli, Massimo F, Richter, Dimitrios, Rosemann, Thomas, Sechtem, Udo, Steg, Ph Gabriel, Vrints, Christian, Luis Zamorano, Jose, Nutrition, obésité et risque thrombotique (NORT), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Roffi, Marco, Patrono, Carlo, Collet, Jean-Philippe, Mueller, Christian, Valgimigli, Marco, Andreotti, Felicita, Bax, Jeroen J, Borger, Michael A, Brotons, Carlo, Chew, Derek P, Gencer, Bari, Hasenfuss, Gerd, Kjeldsen, Keld, Lancellotti, Patrizio, Landmesser, Ulf, Mehilli, Julinda, Mukherjee, Debabrata, Storey, Robert F, Windecker, Stephan, Baumgartner, Helmut, Gaemperli, Oliver, Achenbach, Stephan, Agewall, Stefan, Badimon, Lina, Baigent, Colin, Bueno, Héctor, Bugiardini, Raffaele, Carerj, Scipione, Casselman, Filip, Cuisset, Thoma, Erol, Çetin, Fitzsimons, Donna, Halle, Martin, Hamm, Christian, Hildick-Smith, David, Huber, Kurt, Iliodromitis, Efstathio, James, Stefan, Lewis, Basil S, Lip, Gregory Y H, Piepoli, Massimo F, Richter, Dimitrio, Rosemann, Thoma, Sechtem, Udo, Steg, Ph Gabriel, Vrints, Christian, Luis Zamorano, Jose, ACS - Amsterdam Cardiovascular Sciences, APH - Amsterdam Public Health, and Cardiology

Subjects
High-sensitivity troponin, Ticagrelor, Chest pain unit, medicine.medical_treatment, Atherothrombosis, Myocardial ischaemia, Recommendations, MESH: Risk Assessment, Early invasive strategy, Electrocardiography, Acute cardiac care, Acute coronary syndromes, Angioplasty, Anticoagulation, Apixaban, Aspirin, Beta-blockers, Bivalirudin, Bypass surgery, Cangrelor, Clopidogrel, Dabigatran, Diabetes, Enoxaparin, European society of cardiology, Fondaparinux, Glycoprotein IIb/IIIa inhibitors, Guidelines, Heparin, Nitrates, Non-ST-elevation myocardial infarction, Platelet inhibition, Prasugrel, Revascularization, Rhythm monitoring, Rivaroxaban, Statin, Stent, Unstable angina, Vorapaxar, Cardiology and Cardiovascular Medicine, ST segment, Myocardial infarction, 610 Medicine & health, ComputingMilieux_MISCELLANEOUS, MESH: Platelet Glycoprotein GPIIb-IIIa Complex, Platelet aggregation inhibitor, MESH: Percutaneous Coronary Intervention, MESH: Hemorrhage, medicine.medical_specialty, Acute coronary syndrome, Cardiotonic Agents, MESH: Algorithms, Hemorrhage, Platelet Glycoprotein GPIIb-IIIa Complex, MESH: Anticoagulants, Risk Assessment, Percutaneous Coronary Intervention, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Humans, Acute Coronary Syndrome, Physical Examination, Management of acute coronary syndrome, MESH: Humans, MESH: Cardiotonic Agents, Recommendation, medicine.disease, MESH: Acute Coronary Syndrome, Long-Term Care, MESH: Coronary Angiography, MESH: Non-ST Elevated Myocardial Infarction, Purinergic P2Y Receptor Antagonists, Human medicine, Biomarkers, Guideline, Diabete, Nitrate, Coronary Angiography, MESH: Angina Pectoris, MESH: Long-Term Care, Non-ST Elevated Myocardial Infarction, reproductive and urinary physiology, Atherothrombosi, MESH: Platelet Aggregation Inhibitors, embryonic structures, Cardiology, MESH: Purinergic P2Y Receptor Antagonists, biological phenomena, cell phenomena, and immunity, Algorithms, medicine.drug, Settore BIO/14 - FARMACOLOGIA, Glycoprotein IIb/IIIa inhibitor, European Society of Cardiology, Angina Pectoris, Diagnosis, Differential, MESH: Physical Examination, MESH: Diagnosis, Differential, Internal medicine, medicine, Beta-blocker, urogenital system, business.industry, Percutaneous coronary intervention, Anticoagulants, MESH: Electrocardiography, MESH: Biomarkers, business, Platelet Aggregation Inhibitors
Abstract

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation : The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

Published
2015

15. Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

Author

Niessner, Alexander, primary, Tamargo, Juan, additional, Koller, Lorenz, additional, Saely, Christoph H, additional, Schmidt, Thomas Andersen, additional, Savarese, Gianluigi, additional, Wassmann, Sven, additional, Rosano, Giuseppe, additional, Ceconi, Claudio, additional, Torp-Pedersen, Christian, additional, Kaski, Juan Carlos, additional, Kjeldsen, Keld Per, additional, Agewall, Stefan, additional, Walther, Thomas, additional, Drexel, Heinz, additional, and Lewis, Basil S, additional

Published
2017
Full Text
View/download PDF

16. Comprehensive efforts to increase adherence to statin therapy

Author

Vonbank, Alexander, primary, Agewall, Stefan, additional, Kjeldsen, Keld Per, additional, Lewis, Basil S., additional, Torp-Pedersen, Christian, additional, Ceconi, Claudio, additional, Funck-Brentano, Christian, additional, Kaski, Juan Carlos, additional, Niessner, Alexander, additional, Tamargo, Juan, additional, Walther, Thomas, additional, Wassmann, Sven, additional, Rosano, Giuseppe, additional, Schmidt, Harald, additional, Saely, Christoph H., additional, and Drexel, Heinz, additional

Published
2017
Full Text
View/download PDF

17. Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis

Author

Niessner, Alexander, primary, Tamargo, Juan, additional, Morais, João, additional, Koller, Lorenz, additional, Wassmann, Sven, additional, Husted, Steen Elkjær, additional, Torp-Pedersen, Christian, additional, Kjeldsen, Keld, additional, Lewis, Basil S., additional, Drexel, Heinz, additional, Kaski, Juan Carlos, additional, Atar, Dan, additional, Storey, Robert F., additional, Lip, Gregory Y. H., additional, Verheugt, Freek W. A., additional, and Agewall, Stefan, additional

Published
2015
Full Text
View/download PDF

18. Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management--a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis

Author

Niessner, Alexander, Tamargo, Juan, Morais, João, Koller, Lorenz, Wassmann, Sven, Husted, Steen Elkjær, Torp-Pedersen, Christian, Kjeldsen, Keld, Lewis, Basil S., Drexel, Heinz, Kaski, Juan Carlos, Atar, Dan, Storey, Robert F., Lip, Gregory Y. H., Verheugt, Freek W. A., and Agewall, Stefan

Published
2017
Full Text
View/download PDF

19. Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

Author

Sulzgruber, Patrick, Wassmann, Sven, Semb, Anne Grete, Doehner, Wolfram, Widimsky, Petr, Gremmel, Thomas, Kaski, Juan Carlos, Savarese, Gianluigi, Rosano, Giuseppe M C, Borghi, Claudio, Kjeldsen, Keld, Torp-Pedersen, Christian, Schmidt, Thomas Andersen, Lewis, Basil S, Drexel, Heinz, Tamargo, Juan, Atar, Dan, Agewall, Stefan, and Niessner, Alexander

Published
2019
Full Text
View/download PDF

21. Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.

Author

Gibson CM, Duffy D, Bahit MC, Chi G, White H, Korjian S, Alexander JH, Lincoff AM, Heise M, Kingwell BA, Nicolau JC, Lopes RD, Cornel JH, Lewis BS, Vinereanu D, Goodman SG, Bode C, Steg PG, Libby P, Sacks FM, Bainey KR, Ridker PM, Mahaffey KW, Aylward P, Nicholls SJ, Pocock SJ, Mehran R, and Harrington RA

Abstract

Background and Aims: In the AEGIS-II trial (NCT03473223), CSL112, a human apolipoprotein A1 derived from plasma that increases cholesterol efflux capacity, did not significantly reduce the risk of the primary endpoint through 90 days versus placebo after acute myocardial infarction (MI). Nevertheless, given the well-established relationship between higher low-density lipoprotein cholesterol (LDL-C) and plaque burden, as well as greater risk reductions seen with PCSK9 inhibitors in patients with baseline LDL-C ≥100 mg/dL on statin therapy, the efficacy of CSL112 may be influenced by baseline LDL-C., Methods: Overall, 18,219 patients with acute MI, multivessel coronary artery disease, and additional risk factors were randomized to either four weekly infusions of 6 g CSL112 or placebo. This exploratory post-hoc analysis evaluated cardiovascular outcomes by baseline LDL-C in patients prescribed guideline-directed statin therapy at the time of randomization (n=15,731)., Results: As baseline LDL-C increased, risk of the primary endpoint at 90 days lowered in those treated with CSL112 compared with placebo. In patients with LDL-C ≥100 mg/dL at randomization, there was a significant risk reduction of cardiovascular death, MI, or stroke in the CSL112 vs. placebo group at 90, 180, and 365 days (hazard ratio 0.69 [0.53-0.90], 0.71 [0.57-0.88], and 0.78 [0.65-0.93]). In contrast, there was no difference between treatment groups among those with LDL-C <100 mg/dL at baseline., Conclusions: In this population, treatment with CSL112 compared to placebo was associated with a significantly lower risk of recurrent cardiovascular events among patients with a baseline LDL-C ≥100 mg/dL. Further studies need to confirm that CSL112 efficacy is influenced by baseline LDL-C., (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)

Published
2024
Full Text
View/download PDF

22. Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy.

Author

Crea F, Thiele H, Sibbing D, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, Gale CP, Gilard M, Jobs A, Jüni P, Lambrinou E, Lewis BS, Mehilli J, Meliga E, Merkely B, Mueller C, Roffi M, Rutten FH, Siontis GCM, Barbato E, Collet JP, Giannitsis E, Hamm CW, Böhm M, Cornel JH, Ferreiro JL, Frey N, Huber K, Kubica J, Navarese EP, Mehran R, Morais J, Storey RF, Valgimigli M, Vranckx P, and James S

Subjects
Clopidogrel, Humans, Prasugrel Hydrochloride therapeutic use, Purinergic P2Y Receptor Antagonists, Ticagrelor therapeutic use, Percutaneous Coronary Intervention
Published
2021
Full Text
View/download PDF

23. Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Author

Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, and Lewis BS

Subjects
Cardiology, Cardiovascular Diseases complications, Diabetes Mellitus, Type 2 complications, Dipeptidyl-Peptidase IV Inhibitors therapeutic use, Europe, Glucagon-Like Peptide-1 Receptor agonists, Glycated Hemoglobin metabolism, Glycoside Hydrolase Inhibitors therapeutic use, Humans, Incretins therapeutic use, Metformin therapeutic use, Myocardial Infarction epidemiology, Societies, Medical, Sodium-Glucose Transporter 2 Inhibitors therapeutic use, Stroke epidemiology, Cardiovascular Diseases prevention & control, Diabetes Mellitus, Type 2 drug therapy, Hypoglycemic Agents therapeutic use
Published
2018
Full Text
View/download PDF

24. CardioPulse: Coronary artery disease from prevention to intervention.

Author

Lewis BS

Subjects
Cardiac Imaging Techniques, Congresses as Topic, Humans, Hyperlipidemias prevention & control, Italy, PCSK9 Inhibitors, Thoracic Surgical Procedures, Transcatheter Aortic Valve Replacement, Coronary Artery Disease prevention & control
Published
2016

Catalog

Books, media, physical & digital resources
See catalog results